Hannover, Germany

Angela Steinkamp-Zucht


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 28(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Angela Steinkamp-Zucht

Introduction

Angela Steinkamp-Zucht is a notable inventor based in Hannover, Germany. He has made significant contributions to the field of cytostatic treatment through his innovative research and development. His work focuses on preventing resistance formation in cancer therapies, which is a critical challenge in oncology.

Latest Patents

Angela Steinkamp-Zucht holds a patent titled "Utilization of 5′ substituted nucleosides for resistance formation in cytoclastic treatment, and drug containing these nucleosides, polymers, methods of use and compositions." This invention relates to a method of producing a composition aimed at preventing or reducing the formation of resistance during cytostatic treatment. The composition combines BVDU, a salt thereof, or BVDU in protected form or prodrug form with at least one cytostatic agent. This innovative approach is designed to enhance the effectiveness of cancer treatments by addressing the issue of drug resistance.

Career Highlights

Angela Steinkamp-Zucht has been associated with Resprotect GmbH, where he has contributed to advancing research in the field of cancer treatment. His work has been instrumental in developing new therapeutic strategies that improve patient outcomes.

Collaborations

Angela collaborates with Rudolf Fahrig, working together to enhance the effectiveness of cytostatic treatments through innovative research.

Conclusion

Angela Steinkamp-Zucht's contributions to the field of cytostatic treatment highlight the importance of innovation in overcoming challenges in cancer therapy. His work continues to pave the way for more effective treatment options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…